n.a. (PCYC)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)
Jim Cramer: I'm Making My Peace With This Happy Market

Jim Cramer: I'm Making My Peace With This Happy Market

It's almost comical how welcoming it is these days.

3 Stocks Reiterated As A Hold: PCYC, OXY, AAL

3 Stocks Reiterated As A Hold: PCYC, OXY, AAL

TheStreet Ratings team reiterated 3 stocks with a hold rating on Tuesday

Jim Cramer's 'Mad Money' Recap: This Market Is Happy and So Am I

Jim Cramer's 'Mad Money' Recap: This Market Is Happy and So Am I

Cramer says the market likes just about everything it sees, which is great news since there's a lot to like.

Making My Peace With a Happy Market

It's almost comical how welcoming it is these days.

Cramer: Pharmacyclics-Johnson & Johnson Deal Unlikely at This Price

Cramer: Pharmacyclics-Johnson & Johnson Deal Unlikely at This Price

TheStreet's Jim Cramer said at these prices he isn't expecting J&J to buy the cancer drug company.

A Tough Day to Be Short

A Tough Day to Be Short

Two stocks that could hurt your portfolio.

New Lifetime High Reached By Pharmacyclics (PCYC)

New Lifetime High Reached By Pharmacyclics (PCYC)

Trade-Ideas LLC identified Pharmacyclics (PCYC) as a new lifetime high candidate

Pharmacyclics (PCYC) Is Today's Pre-Market Mover With Heavy Volume Stock

Pharmacyclics (PCYC) Is Today's Pre-Market Mover With Heavy Volume Stock

Trade-Ideas LLC identified Pharmacyclics (PCYC) as a pre-market mover with heavy volume candidate

Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1

Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1

The much ballyhooed J.P. Morgan Healthcare Conference kicks off Monday in San Francisco. Here are capsule summaries of some of the expected story lines from presenting companies.

How to Build a Portfolio

How to Build a Portfolio

It's crucial to avoid being a 'closet indexer'.

Pharmacyclics (PCYC) Is Water-Logged And Getting Wetter Today

Pharmacyclics (PCYC) Is Water-Logged And Getting Wetter Today

Trade-Ideas LLC identified Pharmacyclics (PCYC) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Trade-Ideas: Pharmacyclics (PCYC) Is Today's Post-Market Leader Stock

Trade-Ideas: Pharmacyclics (PCYC) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Pharmacyclics (PCYC) as a post-market leader candidate

Buy These 5 Breakout Health Care Stocks for Healthy Gains

Buy These 5 Breakout Health Care Stocks for Healthy Gains

Health care stocks have the highest relative strength of any sector, an indication that they are outperforming the broad market through rallies and corrections alike.

Roof Leaker To Watch: Pharmacyclics (PCYC)

Roof Leaker To Watch: Pharmacyclics (PCYC)

Trade-Ideas LLC identified Pharmacyclics (PCYC) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate

Build Long-Side Exposure

Those positions might not offer instant profits, but a measured approach should pay off.

'Mad Money' Lightning Round: I Like H&R Block So Buy It

'Mad Money' Lightning Round: I Like H&R Block So Buy It

Cramer prefers Intel over Advanced Micro Devices, thinks you should buy RR Donnelley but wants to hear more about Zillow's merger with Trulia before recommending it.

Jim Cramer's 'Mad Money' Recap: Hooray for the Federal Reserve

Jim Cramer's 'Mad Money' Recap: Hooray for the Federal Reserve

Now that the Fed has done the right thing on monetary policy, investors should stop worrying and start thinking about how to make more money, Cramer says.

5 Stocks Breaking Out With Big Volume

5 Stocks Breaking Out With Big Volume

These stocks rising on unusual volume are within range of triggering breakout trades.

Trade-Ideas: Pharmacyclics (PCYC) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas: Pharmacyclics (PCYC) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas LLC identified Pharmacyclics (PCYC) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Infinity Pharma Snags Abbvie for Blood Cancer Drug Partnership

Infinity Pharma Snags Abbvie for Blood Cancer Drug Partnership

Infinity and Abbvie will jointly develop and market duvelisib.

Biotech, Social Media Stocks Are Less Frothy Than Janet Yellen Thinks

Biotech, Social Media Stocks Are Less Frothy Than Janet Yellen Thinks

A month after Fed Chair Janet Yellen's comments, ETFs covering both groups are pushing towards new highs on strong fundamental backdrops.

Pharmacyclics Has Edge Over Blood Cancer Competitors

Pharmacyclics Has Edge Over Blood Cancer Competitors

Imbruvica will be an important part of the treatment landscape for blood cancers.

3 Stocks Pushing The Drugs Industry Downward

3 Stocks Pushing The Drugs Industry Downward

TheStreet highlights 3 stocks pushing the drugs industry lower today.

Trade-Ideas: Pharmacyclics (PCYC) Is Today's Post-Market Leader Stock

Trade-Ideas: Pharmacyclics (PCYC) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Pharmacyclics (PCYC) as a post-market leader candidate

Gimmicks Won't Smooth Things Over

Something worrisome has me fretting more than I have in a while.

3 Stocks Spiking on Big Volume

3 Stocks Spiking on Big Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Indices Approach Round-Number Resistance

Those levels may not end the bull market, but short-sellers are taking note.

3 Stocks Spiking on Unusual Volume

3 Stocks Spiking on Unusual Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

'Fast Money' Recap: A Mixed Bag for Housing

'Fast Money' Recap: A Mixed Bag for Housing

The trading panel discussed the stock market's big drop, how low the S&P can go and why bonds aren't selling off.